Skip to main content
Article thumbnail
Location of Repository

www.miami.edu/ethics/jpsl Scientific Evidence and the Law: An Objective Bayesian Formalization of The Precautionary Principle In Pharmaceutical Regulation

By Barbara Osimani, Federica Russo, Jon Williamson and Università Cattolica Del Sacro Cuore

Abstract

Abstract The paper considers the legal tools that have been developed in German pharmaceutical regulation as a result of the precautionary attitude inaugurated by the Contergan decision (1970). These tools are (i) the notion of “well-founded suspicion”, which attenuates the requirements for safety intervention by relaxing the requirement of a proved causal connection between danger and source, and the introduction of (ii) the reversal of proof burden in liability norms. The paper focuses on the first and proposes seeing the precautionary principle as an instance of the requirement that one should maximise expected utility. In order to maximise expected utility certain probabilities are required and it is argued that objective Bayesianism offers the most plausible means to determine the optimal decision in cases where evidence supports diverging choices. 1. Precautionary attitudes in response to uncertain knowledge Historically, the precautionary principle arose in response to the lessons learnt from environmental disasters and injuries to human and animal health caused b

Year: 2011
OAI identifier: oai:CiteSeerX.psu:10.1.1.353.338
Provided by: CiteSeerX
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://citeseerx.ist.psu.edu/v... (external link)
  • http://www.kent.ac.uk/secl/phi... (external link)
  • www.miami.edu/ethics/jpsl (external link)
  • Suggested articles


    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.